Non-Hodgkin's lymphoma in a chronic myelocytic leukemia patient treated with imatinib

Non-Hodgkin's lymphoma in a chronic myelocytic leukemia patient treated with imatinib

Show other versions (1)

Imatinib is an important example of tyrosine kinase inhibitors (TKIs) used in clinical practice. Imatinib blocks the ATP binding site of the Bcr-Abl fusion protein and selectively inhibits Bcr-Abl tyrosine kinase (TK) activity. Treatment of chronic myelocytic leukemia (CML) with imatinib is encourag...

Full description

Bibliographic Details
Main Authors:	Semra Paydaş, Berna Bozkurt Duman, Melek Ergin
Format:	Article
Language:	English
Published:	Galenos Publishing House 2011-08-01
Series:	Turkish Journal of Hematology
Subjects:	imatinib chronic myelocytic leukemia non-hodgkin's lymphoma
Online Access:	https://jag.journalagent.com/z4/download_fulltext.asp?pdir=tjh&un=TJH-04909

Similar Items

Non-Hodgkin's lymphoma in a chronic myelocytic leukemia patient treated with imatinib
by: Semra Paydaş, et al.
Published: (2011-09-01)

Hodgkin Lymphoma in a Case of Chronic Myeloid Leukemia Treated with Tyrosine Kinase Inhibitors
by: Smeeta GAJENDRA, et al.
Published: (2019-01-01)

Serious Skin Reaction Associated with Imatinib in a Patient with Chronic Myeloid Leukemia
by: Murat Albayrak, et al.
Published: (2011-12-01)

"Time sequential high dose of Cytarabine in acute myelocytic leukemia "
by: Ghavamzadeh A, et al.
Published: (2003-03-01)

"Time sequential high dose of Cytarabine in acute myelocytic leukemia "
by: Ghavamzadeh A, et al.
Published: (2003-05-01)

Susac syndrome in a patient with chronic myelocytic leukemia: Consequence or coincidence?
by: Arash Maleki, et al.
Published: (2024-03-01)

Combination of a bronchogenic cyst in the thoracic spinal canal with chronic myelocytic leukemia
by: Zhang Hao, et al.
Published: (2023-09-01)

Alteration of gut microbiome and correlated amino acid metabolism are associated with acute myelocytic leukemia carcinogenesis
by: Jing Xu, et al.
Published: (2023-08-01)

IGF2BP2 Overexpression Indicates Poor Survival in Patients with Acute Myelocytic Leukemia
by: Xin He, et al.
Published: (2018-12-01)

Potential Correlation Between Eczema and Hematological Malignancies Risk: A Systematic Review and Meta-Analysis
by: Zuohui Liang, et al.
Published: (2022-06-01)

Searching for a signature involving 10 genes to predict the survival of patients with acute myelocytic leukemia through a combined multi-omics analysis
by: Haifeng Zhuang, et al.
Published: (2020-06-01)

ST11 KPC-2-Producing Klebsiella pneumoniae Isolated from Patient with Acute Myelocytic Leukemia
by: Chen C, et al.
Published: (2024-01-01)

Hodgkin Lymphoma and Hairy Cell Leukemia Arising from Chronic Lymphocytic Leukemia: Case Reports and Literature Review
by: Matteo D’Addona, et al.
Published: (2022-08-01)

IMATINIB IN CHRONIC MYELOID LEUKEMIA: AN OVERVIEW
by: Tomasz Sacha
Published: (2013-12-01)

Curcumin Decreases Viability and Inhibits Proliferation of Imatinib-Sensitive and Imatinib-Resistant Chronic Myeloid Leukemia Cell Lines
by: Esma Bilajac, et al.
Published: (2022-12-01)

Imatinib-induced extensive hyperpigmentation in a case of chronic myeloid leukemia
by: Pradeep Balasubramanian, et al.
Published: (2015-01-01)

Inhibitiory properties of cytoplasmic extract of Lactobacilli isolated from common carp intestine on human chronic myelocytic leukemia K562 cell line: an in vitro study
by: Kabiri F, et al.
Published: (2011-03-01)

Hodgkin Lymphoma Mimicking Osteomyelitis
by: Aneela Majeed, et al.
Published: (2017-06-01)

The role of prophylaxis of bacterial infections in children with acute leukemia/non-Hodgkin lymphoma
by: Elio Castagnola
Published: (2014-06-01)

PATHOBIOLOGY OF HODGKIN LYMPHOMA
by: Claudio Agostinelli, et al.
Published: (2014-06-01)

First research of use Vero-Fludarabine in chronic lymphocytic leukemia and non-hodgkins lymphoma
by: S. S. Bessmeltsev, et al.
Published: (2022-11-01)

Adult Burkitt lymphoma- an Island between lymphomas and leukemias
by: James Turro, et al.
Published: (2019-01-01)

Hyperuricemia and tumor lysis syndrome in children with non-Hodgkin’s lymphoma and acute lymphoblastic leukemia
by: Betül Sevinir, et al.
Published: (2011-03-01)

Hyperuricemia and tumor lysis syndrome in children with non-Hodgkin's lymphoma and acute lymphoblastic leukemia
by: Betül Sevinir, et al.
Published: (2011-03-01)

A Case of Hodgkin Transformation of Chronic Lymphocytic Leukemia
by: Gülden Sincan, et al.
Published: (2016-06-01)

Imatinib Mesylate Treatment in Chronic Myeloid Leukemia
by: Demet Çekdemir, et al.
Published: (2020-03-01)

Treatment outcomes in classic Hodgkin lymphoma: 5‐year update from the Brazilian Hodgkin Lymphoma Registry
by: Irene Biasoli, et al.
Published: (2023-11-01)

A case of metachronous peripheral T‐Cell non‐Hodgkin lymphoma following chemotherapy for Hodgkin disease successfully treated with brentuximab vedotin
by: Federico Meconi, et al.
Published: (2020-08-01)

Renal tuberculosis in an imatinib-treated chronic myeloid leukemia
by: Abhilash Chandra, et al.
Published: (2020-04-01)

Composite follicular lymphoma and classic Hodgkin lymphoma
by: Han-Na Kim, et al.
Published: (2022-01-01)

Atypical Radiologic Image Characterized by Cavitary Lung Lesions in a Case of Hodgkin Lymphoma
by: Mahmut Büyükşimşek, et al.
Published: (2019-02-01)

Atypical Radiologic Image Characterized by Cavitary Lung Lesions in a Case of Hodgkin Lymphoma
by: Mahmut Büyükşimşek, et al.
Published: (2019-03-01)

Long-term treatment outcome in chronic myeloid leukemia patients in accelerated phase treated with imatinib (glevec®)
by: L. A. Antipova, et al.
Published: (2022-11-01)

Erythema multiforme in a patient with recurrent non-hodgkins lymphoma/chronic lymphocytic leukemia
by: Siva Kumara Shankari, et al.
Published: (2012-01-01)

A rare immune-related mesenteric and retroperitoneal serositis in a multirefractory Hodgkin lymphoma patient successfully treated with chylolymphostatic surgery
by: Matteo D'Addona, et al.
Published: (2023-10-01)

OUR EXPERIENCE WITH TREATMENT OF CHRONIC MYELOID LEUKEMIA WITH IMATINIB MESYLATE
by: Mojca Modic, et al.
Published: (2004-12-01)

TREATMENT WITH IMATINIB MESILAT IN CHRONIC MYELOGENOUS LEUKEMIA – OUR EXPERIENCE
by: Mateja Grat, et al.
Published: (2004-12-01)

O tratamento da Leucemia Mielóide Crônica com mesilato de imatinibe Therapy of Chronic Myeloid Leukemia with imatinib mesylate
by: Vaneuza M. Funke, et al.
Published: (2008-04-01)

A case of double leukemia: chronic myeloid leukemia intolerant to imatinib and chronic lymphocytic leukemia
by: Miriana Rocchi
Published: (2015-10-01)

Non-Hodgkin's lymphoma: A review
by: Rohit Singh, et al.
Published: (2020-01-01)